Wenzhi Huang graduated with a Bachelor of Biomedicine from the University of Melbourne, where he developed a strong interest in bioengineering and biomechanics. Motivated by a desire to bridge engineering principles with biomedical applications, he is currently pursuing his Master’s degree at the Mechanobiology and Microfluidics laboratory at the Baker Heart and Diabetes Institute.

His research focuses on developing 3D bioengineered organ-on-a-chip platforms that integrate microfluidic technology, biomechanical stimulation, and multicellular co-culture to replicate the microenvironment of the aortic valve in vitro. These chips are designed to elucidate the cellular and molecular mechanisms underlying valvular calcification, particularly in Calcific Aortic Valve Disease (CAVD), and to provide more physiologically relevant tools for drug screening and therapeutic development.

His interdisciplinary training spans molecular biology, tissue engineering, and microfluidics, positioning him to tackle complex mechanobiological questions. Ultimately, he aspires for his research to contribute to the development of novel therapeutic strategies, helping patients with valvular heart diseases.